Transcription modulation of gene expression in Salmonella enterica serotype Choleraesuis by sub-inhibitory concentrations of ciprofloxacin

Antibiotics promoted the recovery of Microcystis aeruginosa after UV-B radiation at cellular and proteomic levels

Elevated UV-B radiation due to ozone layer depletion may prevent the growth of bloom-forming cyanobacteria in aquatic environments, while antibiotic contaminants may cause effects opposite to that of UV-B due to hormesis. This study investigated the influence of a quaternary antibiotic mixture on Microcystis aeruginosa after UV-B radiation through a 15-day exposure test. UV-B radiation extended the lag phase of M. aeruginosa at doses of 600 and 900 mJ/cm², and significantly (p < 0.05) reduced the growth rate and the F_v/F_m value at doses of 300-900 mJ/cm². Although UV-B radiation significantly (p < 0.05) stimulated the microcystin production ability in each cyanobacterial cell, the total microcystin concentration still significantly (p < 0.05) decreased due to the reduction of cell density. Mixed antibiotics and UV-B regulated the proteomic expression profile of M. aeruginosa in different manners. UV-B radiation upregulated 19 proteins and downregulated 49 proteins in M. aeruginosa, while mixed antibiotics upregulated 45 proteins and downregulated 25 proteins in UV-B treated cells. Mixed antibiotics significantly (p < 0.05) stimulated growth and photosynthesis, increased cell density and microcystin concentration, and reduced oxidative stress in UV-B treated cells through the upregulation of proteins involved in photosynthesis, biosynthesis, cell division, oxidation-reduction, gene expression and microcystin synthesis. This study verified the hypothesis that antibiotics accelerated the recovery of M. aeruginosa from UV-B induced damage. A safe threshold of 20 ng/L was suggested for mixed antibiotics (5 ng/L for each antibiotic), in order to eliminate the stimulatory effects of antibiotics on bloom-forming cyanobacteria.

Nontyphoid salmonella infection: microbiology, clinical features, and antimicrobial therapy

Nontyphoid Salmonella is the most common bacterial pathogen causing gastrointestinal infection worldwide. Most nontyphoid Salmonella infection is limited to uncomplicated gastroenteritis that seldom requires antimicrobial treatment. Nevertheless, invasive infections, such as bacteremia, osteomyelitis, and meningitis, may occur and require antimicrobial therapy. Continuous genetic and genomic evolution in Salmonella leading to increased virulence and resistance to multiple drugs are of significant public health concern. Two major changes in the epidemiology of nontyphoid salmonellosis in Europe and in the USA occurred in the second half of the 20(th) century: the emergence of foodborne human infections caused by Salmonella enterica serotype Enteriditis and by multidrug-resistant strains of Salmonella enterica serotype Typhimurium. In the 21(st) century, a worsening situation is the increasing resistance to fluoroquinolones and third-generation cephalosporins in nontyphoid Salmonella. Clinical isolates showing carbapenem resistance also have been identified. Although antimicrobial therapy is usually not indicated for uncomplicated Salmonella gastroenteritis, recent studies indicated that a short-course ceftriaxone therapy (3-5 days) for patients with severe gastroenteritis would lead to a faster clinical recovery. Continuous surveillance of Salmonella in both humans and animals is mandatory. A better understanding of the mechanisms that lead to the emergence of antimicrobial resistance in Salmonella may help in the devising of better interventional strategies to reduce the spread of resistant Salmonella between humans and reservoirs along the food chain.